Skip to main content
. 2016 Jun 24;65(8):983–994. doi: 10.1007/s00262-016-1861-2

Fig. 4.

Fig. 4

Prognostic factors for time to next treatment and time to progression. To explore the prognostic role of the frequency and ratio (after 3 cycles to baseline) of cell populations for TTNT and TTP, the patients with continuous data were divided into two groups (low vs. high) by a ROC curve analysis. High ratio of CD3after3cycles/baseline+ (≥0.8) (a) and CD8after3cycles/baseline+ (≥0.6) (b) was associated with a longer TTNT. High frequency of NKT-like cells at baseline (≥1.26 %) was an independent factor for TTP (c)